For example, an increased number and size of 53BP1 foci have been observed in patients with NAFLD and advanced fibrosis, which are risk factors for the development of hepatocellular carcinoma [11]. This evidence concerns the gene TP53BP1 and metabolic dysfunction-associated steatotic liver disease.